From: Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer
 | Start | 1 Mon | 3 Mon | 6 Mon | 9 Mon | 12 Mon | 18 Mon | 24 Mon |
---|---|---|---|---|---|---|---|---|
Incomplete Voiding | Â | Â | Â | Â | Â | Â | Â | Â |
Never | 45.1% | 26.8% | 36.6% | 45.6% | 40.4% | 37.8% | 42.9% | 44.1% |
< 1/2 times | 42.2% | 52.5% | 53.7% | 47.2% | 45.2% | 46.7% | 46.0% | 43.3% |
< 1/2 times | 11.2% | 18.0% | 7.4% | 6.8% | 12.0% | 14.6% | 8.8% | 8.8% |
Always | 2.6% | 2.7% | 2.7% | 1.2% | 3.2% | 1.6% | 3.1% | 4.2% |
p | Â | <0.0001 | 0.747 | 0.1302 | 0.5017 | 0.2546 | 0.5802 | 0.7787 |
Intermittency | Â | Â | Â | Â | Â | Â | Â | Â |
Never | 45.9% | 33.3% | 45.1% | 50.0% | 45.2% | 43.5% | 51.3% | 50.8% |
< 1/2 times | 40.3% | 51.0% | 47.5% | 42.4% | 43.6% | 39.4% | 37.2% | 39.1% |
< 1/2 times | 12.3% | 13.4% | 5.1% | 6.8% | 9.2% | 15.4% | 9.7% | 9.2% |
Always | 1.5% | 2.3% | 2.3% | 0.8% | 2.0% | 1.6% | 1.8% | 0.8% |
p | Â | 0.0025 | 0.1411 | 0.0156 | 0.7464 | 0.8765 | 0.1081 | 0.0225 |
Weak Stream | Â | Â | Â | Â | Â | Â | Â | Â |
Never | 42.7% | 26.8% | 37.7% | 42.8% | 37.2% | 34.1% | 41.2% | 40.3% |
< 1/2 times | 40.8% | 46.7% | 48.6% | 42.0% | 43.2% | 48.0% | 41.6% | 45.4% |
< 1/2 times | 11.2% | 22.6% | 10.9% | 13.2% | 16.8% | 13.4% | 12.8% | 10.9% |
Always | 5.2% | 3.8% | 2.7% | 2.0% | 2.8% | 4.5% | 4.4% | 3.4% |
p | Â | <0.0001 | 0.9055 | 0.6035 | 0.1365 | 0.1183 | 0.7275 | 0.6782 |
Straining | Â | Â | Â | Â | Â | Â | Â | Â |
Never | 72.4% | 60.2% | 74.3% | 73.9% | 68.4% | 65.0% | 72.4% | 75.6% |
< 1/2 times | 24.6% | 33.3% | 22.6% | 23.7% | 25.6% | 29.3% | 24.4% | 20.6% |
< 1/2 times | 1.9% | 5.7% | 2.7% | 2.4% | 4.8% | 5.3% | 3.1% | 3.4% |
Always | 1.1% | 0.8% | 0.4% | 0.0% | 1.2% | 0.4% | 0.4% | 0.4% |
p | Â | 0.0001 | 0.7224 | 0.2286 | 0.1191 | 0.0482 | 0.7608 | 0.3241 |